Using statins may slow the occurrence of new brain injury caused by lesions associated with multiple sclerosis, new research has shown.
Twice the proportion of patients that were administered statins over a 12-month period did not develop new lesions compared to the control group, who were given placebo, according to the University of California study, which is presented at the American Academy of Neurology.
However, researchers believe that another, larger study will be necessary to confirm the beneficial effects of the cholesterol-lowering drug.
Participants received an 80 milligram daily dose of atorvastatin as part of the trial, with co-author of the study Emmanuelle Waubant underlining the importance of better understanding the effects of this inexpensive drug for future treatment development.
She said this would "better inform physicians and patients of their effect since these drugs are so broadly used throughout the United States and the world, and to learn whether a relatively inexpensive oral therapy can slow the course of disease".
In August, researchers at Stanford University School of Medicine found that an inexpensive hypertension drug known as lisinopril may be beneficial as a multiple sclerosis treatment.
News from Serious Law, specialist acquired brain injury solicitors